Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population
The COVID-19 pandemic has flared across every part of the globe and affected populations from different age groups differently. People aged from 40 to 80 years or older are at an increased risk of morbidity and mortality due to COVID-19. Therefore, there is an urgent requirement to develop therapeut...
Main Authors: | Vivek P. Chavda, Divya Teli, Pankti C. Balar, Dixa Vaghela, Hetvi K. Solanki, Akta Vaishnav, Lalitkumar Vora |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/5/2332 |
Similar Items
-
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
by: Divya Teli, et al.
Published: (2023-02-01) -
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
by: Vivek P. Chavda, et al.
Published: (2023-01-01) -
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
by: Zoufang Huang, et al.
Published: (2022-04-01) -
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
by: Rana Abdelnabi, et al.
Published: (2021-10-01) -
FAVIPIRAVIR AND DEXAMETHASONE IN MANAGEMENT OF SARS-COV2 INFECTION
by: M. Latief, et al.
Published: (2021-05-01)